Figure 3

Progression-free survival of PCa patients treated with androgen deprivation therapy stratified by Gleason score or mast cell infiltration. (A) Progression-free survival of PCa patients with high and low Gleason scores. (B) Progression-free survival of PCa patients with high and low mast cell (MC) counts. High Gleason score, GS⩾8; low Gleason score, GS⩽7. High MC group, >16, low MC group, ⩽16.